COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

January 5, 2021
Case Report
Open Access

Burton's Agammaglobulinemia and COVID-19

Curēus
Justin G HoveyDruhan Howell
January 6, 2021
Preprint
Open Access

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection

BioRxiv : the Preprint Server for Biology
Emma S WinklerMichael S Diamond
January 16, 2021

Covid-19: Convalescent plasma may cut deaths in patients not on ventilation, study indicates

BMJ : British Medical Journal
Jacqui Wise
January 8, 2021
Open Access

SARS-CoV-2 infection associated with hepatitis in an infant with X-linked severe combined immunodeficiency

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Nicolai S C van OersChristian A Wysocki
January 8, 2021
Review
Open Access

Active vitamin D supplementation and COVID-19 infections: review

Irish Journal of Medical Science
Nakhoul FaridNakhoul Nakhoul
January 16, 2021
Case Report
Open Access

Complement Inhibition in Severe COVID-19 Acute Respiratory Distress Syndrome

Frontiers in Pediatrics
Sharmila RaghunandanSatheesh Chonat
January 13, 2021

Nature and dimensions of the systemic hyper-inflammation and its attenuation by convalescent plasma in severe COVID-19

The Journal of Infectious Diseases
Purbita BandopadhyayDipyaman Ganguly
January 20, 2021
Preprint
Open Access

The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated with Convalescent Plasma

MedRxiv : the Preprint Server for Health Sciences
T. MaNigel Paneth
January 6, 2021
Preprint
Open Access

Self-organized stem cell-derived human lung buds with proximo-distal patterning and novel targets of SARS-CoV-2

BioRxiv : the Preprint Server for Biology
E A Rosado-OlivieriA H Brivanlou
January 6, 2021
Preprint
Open Access

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma

BioRxiv : the Preprint Server for Biology
William N VossGregory C Ippolito
January 10, 2021
Review
Open Access

Immune reactivity during COVID-19: Implications for treatment

Immunology Letters
Claudio NapoliMariangela Rusciano
January 16, 2021
Case Report
Open Access

COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery

Journal of Clinical and Translational Hepatology
Ashok ChoudhuryShiv Kumar Sarin
January 8, 2021

COVID-19 convalescent plasma and the SARS-CoV-2 neutralizing titer

The Journal of Infectious Diseases
Evan M BlochAaron A R Tobian
January 15, 2021
Preprint
Open Access

Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mice and non-human primates

BioRxiv : the Preprint Server for Biology
Nerea ZabaletaLuk H Vandenberghe
January 9, 2021

Temporal Analysis of Serial Donations Reveals Decrease in Neutralizing Capacity and Justifies Revised Qualifying Criteria for COVID-19 Convalescent Plasma

The Journal of Infectious Diseases
Roxie C GirardinKathleen A McDonough
January 15, 2021
Preprint
Open Access

Emergence of multiple SARS-CoV-2 mutations in an immunocompromised host

MedRxiv : the Preprint Server for Health Sciences
Elham KhatamzasM. Antwerpen
January 14, 2021
Open Access

Evaluation of the initial response in clinical trial efforts for COVID-19 in Brazil

Revista brasileira de epidemiologia = Brazilian journal of epidemiology
Tatiane Bomfim RibeiroDaniela Oliveira de Melo
January 6, 2021
Review
Open Access

Passive immunization and its rebirth in the era of the COVID-19 pandemic

International Journal of Antimicrobial Agents
Charles S Pavia, Gary P Wormser
January 7, 2021

Retraction: A review of convalescent plasma transfusion in COVID-19: Old wine reserved for special occasions

Lung India : Official Organ of Indian Chest Society

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/covid-19-covalescent-plasma-therapy/9f06ec2a-0b2a-44e7-b15d-4926bd88eebc